2,121
Participants
Start Date
July 31, 2023
Primary Completion Date
September 30, 2027
Study Completion Date
September 30, 2027
CAd3
CAd3 candidate vaccine which is one of the investigational products
ChAdox1
ChAdox1 candidate vaccine which is one of the investigational products
rVSV-SUDV
rVSV-SUDV candidate vaccine which is one of the investigational products
Control
Placebo
Collaborators (1)
Makerere University Lung Institute
UNKNOWN
MRC/UVRI and LSHTM Uganda Research Unit
OTHER
Makerere University Walter Reed Program
UNKNOWN
Epicentre
OTHER
Uganda Virus Research Institute-International Aids Vaccine Initiative
UNKNOWN
Ministry of Health, Uganda
OTHER_GOV
Makerere University
OTHER